Prestige Consumer Healthcare Pre-Tax Profit Margin 2010-2025 | PBH
Prestige Consumer Healthcare pre-tax profit margin from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Prestige Consumer Healthcare Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-03-31 | $1.14B | $0.28B | 24.96% |
| 2024-12-31 | $1.12B | $0.28B | 24.78% |
| 2024-09-30 | $1.11B | $0.27B | 24.03% |
| 2024-06-30 | $1.11B | $0.27B | 23.81% |
| 2024-03-31 | $1.13B | $0.28B | 24.53% |
| 2023-12-31 | $1.13B | $-0.09B | -8.02% |
| 2023-09-30 | $1.13B | $-0.09B | -8.25% |
| 2023-06-30 | $1.13B | $-0.10B | -8.50% |
| 2023-03-31 | $1.13B | $-0.09B | -8.33% |
| 2022-12-31 | $1.11B | $0.27B | 24.08% |
| 2022-09-30 | $1.11B | $0.26B | 23.85% |
| 2022-06-30 | $1.09B | $0.26B | 23.49% |
| 2022-03-31 | $1.09B | $0.26B | 24.13% |
| 2021-12-31 | $1.06B | $0.24B | 22.80% |
| 2021-09-30 | $1.02B | $0.23B | 22.50% |
| 2021-06-30 | $0.98B | $0.22B | 22.58% |
| 2021-03-31 | $0.94B | $0.20B | 21.63% |
| 2020-12-31 | $0.96B | $0.22B | 22.49% |
| 2020-09-30 | $0.96B | $0.21B | 22.11% |
| 2020-06-30 | $0.96B | $0.20B | 21.25% |
| 2020-03-31 | $0.96B | $0.19B | 19.94% |
| 2019-12-31 | $0.95B | $-0.04B | -3.99% |
| 2019-09-30 | $0.95B | $-0.04B | -3.99% |
| 2019-06-30 | $0.95B | $-0.04B | -3.99% |
| 2019-03-31 | $0.98B | $-0.04B | -3.90% |
| 2018-12-31 | $0.99B | $0.09B | 8.89% |
| 2018-09-30 | $1.02B | $0.10B | 9.31% |
| 2018-06-30 | $1.04B | $0.10B | 9.62% |
| 2018-03-31 | $1.04B | $0.11B | 10.27% |
| 2017-12-31 | $1.03B | $0.18B | 17.43% |
| 2017-09-30 | $0.97B | $0.17B | 17.68% |
| 2017-06-30 | $0.93B | $0.17B | 18.60% |
| 2017-03-31 | $0.88B | $0.11B | 12.57% |
| 2016-12-31 | $0.85B | $0.12B | 13.76% |
| 2016-09-30 | $0.83B | $0.11B | 13.09% |
| 2016-06-30 | $0.82B | $0.11B | 13.11% |
| 2016-03-31 | $0.81B | $0.16B | 19.48% |
| 2015-12-31 | $0.79B | $0.17B | 21.45% |
| 2015-09-30 | $0.79B | $0.16B | 20.36% |
| 2015-06-30 | $0.76B | $0.14B | 18.27% |
| 2015-03-31 | $0.72B | $0.13B | 17.76% |
| 2014-12-31 | $0.67B | $0.12B | 17.51% |
| 2014-09-30 | $0.62B | $0.09B | 14.15% |
| 2014-06-30 | $0.60B | $0.10B | 15.97% |
| 2014-03-31 | $0.60B | $0.10B | 17.06% |
| 2013-12-31 | $0.61B | $0.11B | 17.33% |
| 2013-09-30 | $0.62B | $0.12B | 19.48% |
| 2013-06-30 | $0.62B | $0.12B | 18.67% |
| 2013-03-31 | $0.62B | $0.11B | 16.94% |
| 2012-12-31 | $0.60B | $0.08B | 12.60% |
| 2012-09-30 | $0.55B | $0.07B | 13.11% |
| 2012-06-30 | $0.49B | $0.06B | 12.58% |
| 2012-03-31 | $0.44B | $0.06B | 14.06% |
| 2011-12-31 | $0.40B | $0.07B | 17.62% |
| 2011-09-30 | $0.39B | $0.06B | 15.46% |
| 2011-06-30 | $0.36B | $0.06B | 15.83% |
| 2011-03-31 | $0.34B | $0.05B | 14.29% |
| 2010-12-31 | $0.31B | $0.05B | 14.98% |
| 2010-09-30 | $0.29B | $0.06B | 20.34% |
| 2010-06-30 | $0.29B | $0.06B | 18.77% |
| 2010-03-31 | $0.29B | $0.05B | 18.09% |
| 2009-12-31 | $0.28B | $-0.19B | -68.55% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $4.233B | $1.138B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.407B | 27.95 |
| Boston Scientific (BSX) | United States | $155.727B | 38.99 |
| Stryker (SYK) | United States | $146.049B | 30.54 |
| EssilorLuxottica (ESLOY) | France | $127.608B | 0.00 |
| Medtronic (MDT) | Ireland | $106.425B | 15.09 |
| Haleon (HLN) | United Kingdom | $51.105B | 29.10 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.009B | 0.00 |
| ResMed (RMD) | United States | $35.893B | 26.96 |
| GE HealthCare Technologies (GEHC) | United States | $32.299B | 15.34 |
| Agilent Technologies (A) | United States | $31.909B | 20.73 |
| Terumo (TRUMY) | Japan | $27.168B | 35.29 |
| Insulet (PODD) | United States | $22.874B | 89.79 |
| Koninklijke Philips (PHG) | Netherlands | $21.656B | 15.57 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.236B | 11.71 |
| Baxter (BAX) | United States | $15.652B | 11.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.683B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.175B | 21.49 |
| Lantheus Holdings (LNTH) | United States | $5.228B | 13.19 |
| Perrigo (PRGO) | Ireland | $3.680B | 9.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.319B | 24.48 |
| Haemonetics (HAE) | United States | $3.253B | 14.82 |
| Envista Holdings (NVST) | United States | $3.097B | 25.73 |
| GN Store Nord (GNNDY) | Denmark | $2.224B | 18.42 |
| QuidelOrtho (QDEL) | United States | $2.074B | 14.27 |
| LeMaitre Vascular (LMAT) | United States | $1.857B | 41.51 |
| AtriCure (ATRC) | United States | $1.711B | 0.00 |
| Acuren (TIC) | United States | $1.276B | 0.00 |
| Neogen (NEOG) | United States | $1.272B | 16.28 |
| AdaptHealth (AHCO) | United States | $1.212B | 12.30 |
| Kestra Medical Technologies (KMTS) | United States | $1.156B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.109B | 24.95 |
| BioLife Solutions (BLFS) | United States | $1.039B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.990B | 12.65 |
| InMode (INMD) | Israel | $0.927B | 9.34 |
| CeriBell (CBLL) | United States | $0.608B | 0.00 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.573B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.550B | 0.00 |
| Valneva SE (VALN) | France | $0.535B | 0.00 |
| Owens & Minor (OMI) | United States | $0.510B | 4.23 |
| Capricor Therapeutics (CAPR) | United States | $0.452B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.428B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.316B | 11.62 |
| Aurora Cannabis (ACB) | Canada | $0.298B | 53.00 |
| Cresco Labs (CRLBF) | United States | $0.295B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.263B | 22.17 |
| Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
| ZimVie (ZIMV) | United States | $0.255B | 11.57 |
| Cerus (CERS) | United States | $0.243B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.243B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.229B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.224B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.215B | 0.00 |
| Quanterix (QTRX) | United States | $0.202B | 0.00 |
| Brainsway (BWAY) | Israel | $0.193B | 51.00 |
| Biote (BTMD) | United States | $0.189B | 5.32 |
| TriSalus Life Sciences (TLSI) | United States | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Omeros (OMER) | United States | $0.181B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.179B | 14.57 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 0.00 |
| Jin Medical (ZJYL) | China | $0.118B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| Agape ATP (ATPC) | $0.087B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| United Health Products (UEEC) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.18 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.029B | 38.86 |
| Safety Shot (SHOT) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |